Browse All

Current Filters

CLEAR FILTER x

TITLE

High-Efficacy Therapies Reduce Clinical and Radiological Events More Effectively than Traditional Treatments in Neuromyelitis Optica Spectrum Disorder

Author:Moog, Tatum   Smith, Alexander   McCreary, Morgan   Burgess, Katy   Okuda, Darin   

Session Name:S50: Autoimmune Neurology: NMOSD  

Topic:Autoimmune Neurology  

Program Number:S50.008  

Author Institution:The University of Texas Southwestern Medical Center, Dallas, TX  

Retina and optic nerve diffusion restriction in acute central retinal artery occlusion

Author:Gomez Ramos, Daniel   Harahsheh, Ehab   Zhang, Nan   Parikh, Parth   Elshaigi, Omer   Rath, Tanya   Hoxworth, Joseph   Dumitrascu, Oana   

Session Name:P2: Neuro-ophthalmology/Neuro-otology: Clinical Research of the Afferent Visual System  

Topic:Neuro-ophthalmology/Neuro-otology  

Program Number:P2.007  

Author Institution:Mayo Clinic, Scottsdale, AZ  Mayo Clinic College of Medicine, Scottsdale, AZ  Mayo Clinic Arizona, Scottsdale, AZ  Mayo Clinic, Gilbert, AZ  Mayo Clinic , Scottsdale, AZ  Mayo Clinic, Phoenix, AZ  

A retrospective survival analysis of relapse rate in pediatric and adult autoimmune encephalitis

Author:Yang, Jennifer   Liu, Emilie   Nguyen, Linda   Dunn-Pirio, Anastasie   Graves, Jennifer   

Session Name:P4: Autoimmune Neurology: Autoimmune Encephalitis / Paraneoplastic / Stiff-Person Syndrome / Immunotherapy (IrAe)  

Topic:Autoimmune Neurology  

Program Number:P4.003  

Author Institution:University of California, San Diego, La Jolla, CA  University of California, San Diego, San Diego, CA  University of Texas Southwestern, Dallas, TX  

Patterns and Predictors of Multiple Sclerosis Phenotype Transitions: A Longitudinal Analysis Using the CLIMB Study

Author:Bose, Gauruv   Greene, Nupur   Healy, Brian C.   Weiner, Howard   Farnett, Lisa   Higuchi, Keiko   Chitnis, Tanuja   

Session Name:P5: MS Prognosis/Epidemiology  

Topic:MS and Inflammatory Disease  

Program Number:P5.018  

Author Institution:Brigham and Women’s Hospital  and University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada  Sanofi, Cambridge, MA  Brigham and Women’s Hospital Boston, Boston, MA  Brigham and Women's Hospital  and Harvard Medical School, Boston, MA  Sanofi, San Antonio, TX  

Alzheimer’s Disease Linkage to Evidence (AD-LINE) Study Early Results: Linking Real-World Claims Data to Phase III GRADUATE Study of Gantenerumab

Author:Wallick, Chris   Fillit, Howard   Tcheremissine, Oleg   Abbass, Ibrahim M   Ng, Carmen   To, Tu My   Seleri, Sheila   

Session Name:P7: Aging and Dementia: Therapeutics 1  

Topic:Aging and Dementia  

Program Number:P7.009  

Author Institution:Genentech, Inc., a member of the Roche Group, South San Francisco, CA  Departments of Geriatric Medicine, Medicine, and Neuroscience, Icahn School of Medicine and Mt. Sinai, New York, NY  Atrium Health Behavioral Health Charlotte , Charlotte, NC